# Efficacy of Ciclesonide vs Placebo Administered as Once Daily or Twice Daily in Patients Not Treated With Inhaled Corticosteroid.

> **NCT00174720** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 708 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Ciclesonide (XRP1526)

## Key facts

- **NCT ID:** NCT00174720
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2007-02
- **Final completion:** 2007-02
- **Target enrollment:** 708 (ACTUAL)
- **Last updated:** 2009-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00174720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00174720, "Efficacy of Ciclesonide vs Placebo Administered as Once Daily or Twice Daily in Patients Not Treated With Inhaled Corticosteroid.". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00174720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*